The redox switch that regulates molecular chaperones

Biomolecular Concepts

Volumn 6, Issue 4, 2015, Pages 269-284

  Conway, Myra E ^a   Lee, Christopher ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

CXXC motifs; human branched chain aminotransferase protein; molecular chaperones; neurodegeneration; peroxiredoxins; protein disulphide isomerase; protein folding; S nitrosylation

Indexed keywords

AMINOTRANSFERASE; CHAPERONE; DISULFIDE; HEAT SHOCK PROTEIN; PEROXIREDOXIN; PROTEIN DISULFIDE ISOMERASE;

ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN FOLDING;

ANIMALS; DISULFIDES; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PEROXIREDOXINS; PROTEIN DISULFIDE-ISOMERASES; PROTEIN FOLDING; TRANSAMINASES;

EID: 84939233300     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc-2015-0015     Document Type: Review

References (120)

1. Droge W. Redox regulation in anabolic and catabolic processes. Curr Opin Clin Nutr 2006; 9: 190-5.
2. Holmgren A, Johansson C, Berndt C, Lonn ME, Hudemann C, Lillig CH. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 2005; 33: 1375-7.
3. Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radical Biol Med 2014; 66: 75-87.
4. Lipinski B. Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev 2011; 2011: 809696.
5. Ghezzi P. Protein glutathionylation in health and disease. Biochim Biophys Acta 2013; 1830: 3165-72.
6. Alfadda AA, Sallam RM. Reactive oxygen species in health and disease. J Biomed Biotechnol 2012; 2012: 936486.
7. Groitl B, Jakob U. Thiol-based redox switches. Biochim Biophys Acta 2014; 1844: 1335-43.
8. Poole LB. The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med 2015; 80: 148-57.
9. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM. Identification of a peroxide-sensitive redox switch at the CXXC motif in the human mitochondrial branched chain aminotransferase. Biochemistry 2002; 41: 9070-8.
10. Furdui CM, Poole LB. Chemical approaches to detect and analyze protein sulfenic acids. Mass Spectrom Rev 2014; 33: 126-46.
11. Conway ME, Poole LB, Hutson SM. Roles for cysteine residues in the regulatory CXXC motif of human mitochondrial branched chain aminotransferase enzyme. Biochemistry 2004; 43: 7356-64.
12. Ginter E, Simko V, Panakova V. Antioxidants in health and disease. Bratisl Lek Listy 2014; 115: 603-6.
13. Woo HA, Jeong W, Chang TS, Park KJ, Park SJ, Yang JS, Rhee SG. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem 2005; 280: 3125-8.
14. Jeong W, Bae SH, Toledano MB, Rhee SG. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radic Biol Med 2012; 53: 447-56.
15. Berndt C, Lillig CH, Holmgren A. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta 2008; 1783: 641-50.
16. Coles SJ, Hancock JT, Conway ME. Differential redox potential between the human cytosolic and mitochondrial branched-chain aminotransferase. Acta Biochim Biophys Sin 2012; 44: 172-6.
17. Kallis GB, Holmgren A. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J Biol Chem 1980; 255: 10261-5.
18. Niforou K, Cheimonidou C, Trougakos IP. Molecular chaperones and proteostasis regulation during redox imbalance. Redox Biol 2014; 2: 323-32.
19. Conway ME, Harris M. S-nitrosylation of the thioredoxin-like domains of protein disulfide isomerase and its role in neurode-generative conditions. Front Chem 2015; 3: 27.
20. Blair LJ, Baker JD, Sabbagh JJ, Dickey CA. The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease. J Neurochem 2015; 133: 1-13.
21. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992; 355: 33-45.
22. Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol 2013; 14: 630-42.
23. Goloubinoff P, De Los Rios P. The mechanism of Hsp70 chaper-ones: (entropic) pulling the models together. Trends Biochem Sci 2007; 32: 372-80.
24. Shorter J. The mammalian disaggregase machinery: Hsp110 syn-ergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS One 2011; 6: e26319.
25. Tiwari BS, Belenghi B, Levine A. Oxidative stress increased respiration and generation of reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant Physiol 2002; 128: 1271-81.
26. Leist M, Single B, Naumann H, Fava E, Simon B, Kuhnle S, Nicotera P. Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem Biophys Res Com-mun 1999; 258: 215-21.
27. Kumsta C, Jakob U. Redox-regulated chaperones. Biochemistry 2009; 48: 4666-76.
28. Garrido C, Paul C, Seigneuric R, Kampinga HH. The small heat shock proteins family: the long forgotten chaperones. Int J Biochem Cell B 2012; 44: 1588-92.
29. Kampinga HH, Garrido C. HSPBs: small proteins with big implications in human disease. Int J Biochem Cell B 2012; 44: 1706-10.
30. De Jong WW, Leunissen JA, Voorter CE. Evolution of the α-crystallin/small heat-shock protein family. Mol Biol Evol 1993; 10: 103-26.
31. Fuchs M, Poirier DJ, Seguin SJ, Lambert H, Carra S, Charette SJ, Landry J. Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem J 2010; 425: 245-55.
32. Pivovarova AV, Chebotareva NA, Kremneva EV, Lappalainen P, Levitsky DI. Effects of actin-binding proteins on the thermal stability of monomeric actin. Biochemistry 2013; 52: 152-60.
33. Batista-Nascimento L, Neef DW, Liu PC, Rodrigues-Pousada C, Thiele DJ. Deciphering human heat shock transcription factor 1 regulation via post-translational modification in yeast. PLoS One 2011; 6: e15976.
34. Herbomel G, Kloster-Landsberg M, Folco EG, Col E, Usson Y, Vourc'h C, Delon A, Souchier C. Dynamics of the full length and mutated heat shock factor 1 in human cells. PLoS One 2013; 8: e67566.
35. Rhee SG, Woo HA, Kil IS, Bae SH. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem 2012; 287: 4403-10.
36. Hall A, Nelson K, Poole LB, Karplus PA. Structure-based insights into the catalytic power and conformational dexterity of perox-iredoxins. Antioxid Redox Signal 2011; 15: 795-815.
37. Hall A, Karplus PA, Poole LB. Typical 2-Cys peroxiredoxins-structures, mechanisms and functions. FEBS J 2009; 276: 2469-77.
38. Wood ZA, Poole LB, Hantgan RR, Karplus PA. Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredox-ins. Biochemistry 2002; 41: 5493-504.
39. Woo HA, Kang SW, Kim HK, Yang KS, Chae HZ, Rhee SG. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J Biol Chem 2003; 278: 47361-4.
40. Knoops B, Loumaye E, Van Der Eecken V. Evolution of the perox-iredoxins. Subcell Biochem 2007; 44: 27-40.
41. Gil-Mohapel J, Brocardo PS, Christie BR. The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates? Curr Drug Targets 2014; 15: 454-68.
42. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 2003; 300: 653-6.
43. Jang HH, Lee KO, Chi YH, Jung BG, Park SK, Park JH, Lee JR, Lee SS, Moon JC, Yun JW, Choi YO, Kim WY, Kang JS, Cheong GW, Yun DJ, Rhee SG, Cho MJ, Lee SY. Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004; 117: 625-35.
44. 2-induced cell death. J Biol Chem 2005; 280: 28775-84.
45. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 2002; 383: 347-64.
46. Wood ZA, Schroder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003; 28: 32-40.
47. Wilkinson B, Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta 2004; 1699: 35-44.
48. Appenzeller-Herzog C, Ellgaard L. The human PDI family: versatility packed into a single fold. Biochim Biophys Acta 2008; 1783: 535-48.
49. Wang C, Li W, Ren J, Fang J, Ke H, Gong W, Feng W, Wang C. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase. Antioxid Redox Signal 2013; 19: 36-45.
50. Wang C, Chen S, Wang X, Wang L, Wallis AK, Freedman RB, Wang CC. Plasticity of human protein disulfide isomerase: evidence for mobility around the X-linker region and its functional significance. J Biol Chem 2010; 285: 26788-97.
51. Klappa P, Ruddock LW, Darby NJ, Freedman RB. The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J 1998; 17: 927-35.
52. Freedman RB, Klappa P, Ruddock LW. Model peptide substrates and ligands in analysis of action of mammalian protein disulfide-isomerase. Methods Enzymol 2002; 348: 342-54.
53. Cai H, Wang CC, Tsou CL. Chaperone-like activity of protein disulfide isomerase in the refolding of a protein with no disulfide bonds. J Biol Chem 1994; 269: 24550-2.
54. Song JL, Wang CC. Chaperone-like activity of protein disulfide-isomerase in the refolding of rhodanese. Eur J Biochem 1995; 231: 312-6.
55. Yao Y, Zhou Y, Wand C. Both the isomerases and chaperone activities of protein disulfide isomerase are required for the reactivation of reduced and denatured acidic phospholipase A2. EMBO J 1997; 16: 651-8.
56. Molinari M, Galli C, Piccaluga V, Pieren M, Paganetti P. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J Cell Biol 2002; 158: 247-57.
57. Versteeg HH, Ruf W. Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxi-doreductase activity. J Biol Chem 2007; 282: 25416-24.
58. Schultz-Norton J, Mcdonald W, Yates J, Narduli A. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol Endocrinol 2006; 20: 1982-95.
59. Van Lith M, Karala AR, Bown D, Gatehouse JA, Ruddock LW, Saunders PT, Benham AM. A developmentally regulated chap-erone complex for the endoplasmic reticulum of male haploid germ cells. Mol Biol Cell 2007; 18: 2795-804.
60. Tsai B, Rodighiero C, Lencer WI, Rapoport TA. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 2001; 104: 937-48.
61. Tsai B, Rapoport TA. Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1. J Cell Biol 2002; 159: 207-16.
62. Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CX, Laurindo FR. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 2005; 280: 40813-9.
63. De APaM, Verissimo-Filho S, Guimaraes LL, Silva AC, Takiuti JT, Santos CX, Janiszewski M, Laurindo FR, Lopes LR. Protein disulfide isomerase redox-dependent association with p47(phox): evidence for an organizer role in leukocyte NADPH oxidase activation. J Leukoc Biol 2011; 90: 799-810.
64. Lumb RA, Bulleid NJ. Is protein disulfide isomerase a redox-dependent molecular chaperone? EMBO J 2002; 21: 6763-70.
65. Wallis AK, Sidhu A, Byrne LJ, Howard MJ, Ruddock LW, Williamson RA, Freedman RB. The ligand-binding b' domain of human protein disulphide-isomerase mediates homodimeriza-tion. Protein Sci 2009; 18: 2569-77.
66. Byrne LJ, Sidhu A, Wallis AK, Ruddock LW, Freedman RB, Howard MJ, Williamson RA. Mapping of the ligand-binding site on the b' domain of human PDI: interaction with peptide ligands and the x-linker region. Biochem J 2009; 423: 209-17.
67. Bastos-Aristizabal S, Kozlov G, Gehring K. Structural insight into the dimerization of human protein disulfide isomerase. Protein Sci 2014; 23: 618-26.
68. Yang S, Wang X, Cui L, Ding X, Niu L, Yang F, Wang C, Wang CC, Lou J. Compact conformations of human protein disulfide isomerase. PLoS One 2014; 9: e103472.
69. Conway ME, Hustson S. The cytosolic and mitochondrial branched chain amino transferase. In: Rajendram R, Preedy V, Vinood P, editors. Branched chain amino acids in clinical nutrition. New York: Springer, 2012: 25-40.
70. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998; 68: 72-81.
71. Hull J, Hindy ME, Kehoe PG, Chalmers K, Love S, Conway ME. Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation. J Neuro-chem 2012; 123: 997-1009.
72. Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM. Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab 2004; 286: E64-76.
73. Garcia-Espinosa MA, Wallin R, Hutson SM, Sweatt AJ. Widespread neuronal expression of branched-chain aminotransferase in the CNS: implications for leucine/glutamate metabolism and for signaling by amino acids. J Neurochem 2007; 100: 1458-68.
74. Karpeisky MY, Ivanov VI. A molecular mechanism for enzymatic transamination. Nature 1966; 210: 493-6.
75. Ichihara A, Koyama E. Transaminase of branched chain amino acids: I. Branched chain amino acids-α-ketoglutarate transami-nase. J Biochem 1966; 59: 160-9.
76. Conway E, Hutson SM. The cytosolic and mitochondrial branched chain aminotransferase. In: Rajendram R, Preedy V, Petel V, editors. Branched chain amino acids in clinical nutrition. New York: Springer, 2015. 25-40.
77. Yennawar NH, Conway ME, Yennawar HP, Farber GK, Hutson SM. Crystal structures of human mitochondrial branched chain ami-notransferase reaction intermediates: ketimine and pyridoxam-ine phosphate forms. Biochemistry 2002; 41: 11592-601.
78. Goto M, Miyahara I, Hirotsu K, Conway M, Yennawar N, Islam MM, Hutson SM. Structural determinants for branched-chain aminotransferase isozyme-specific inhibition by the anti-convulsant drug gabapentin. J Biol Chem 2005; 280: 37246-56.
79. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM. Human mitochondrial branched chain aminotransferase: structural basis for substrate specificity and role of redox active cysteines. Biochim Biophys Acta 2003; 1647: 61-5.
80. Conway ME, Coles SJ, Islam MM, Hutson SM. Regulatory control of human cytosolic branched-chain aminotransferase by oxidation and S-glutathionylation and its interactions with redox sensitive neuronal proteins. Biochemistry 2008; 47: 5465-79.
81. Coles SJ, Easton P, Sharrod H, Hutson SM, Hancock J, Patel VB, Conway ME. S-nitrosoglutathione inactivation of the mito-chondrial and cytosolic BCAT proteins: S-nitrosation and S-thiolation. Biochemistry 2009; 48: 645-56.
82. Hutson SM, Poole LB, Coles SJ, Conway ME. Redox regulation and trapping sulphenic acid in the peroxide sensitive human mitochondrial branched chain aminotransferase. Method Mol Biol 2009; 476: 135-48.
83. Yennawar NH, Islam MM, Conway M, Wallin R, Hutson SM. Human mitochondrial branched chain aminotransferase isozyme: structural role of the CXXC center in catalysis. J Biol Chem 2006; 281: 39660-71.
84. Islam MM, Nautiyal M, Wynn RM, Mobley JA, Chuang DT, Hutson SM. Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm). J Biol Chem 2010; 285: 265-76.
85. El Hindy M, Hezwani M, Corry D, Hull J, El Amraoui F, Harris M, Lee C, Forshaw T, Wilson A, Mansbridge A, Hassler M, Patel VB, Kehoe PG, Love S, Conway ME. The branched-chain ami-notransferase proteins: novel redox chaperones for protein disulfide isomerase-implications in Alzheimer's disease. Antioxid Redox Signal 2014; 20: 2497-513.
86. Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol 2015; 4: 193-9.
87. Lloret A, Fuchsberger T, Giraldo E, Vina J. Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer's disease. Free Radic Biol Med 2015; 83: 186-91.
88. Borza LR. A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neu-rodegenerative diseases. Rev Med Chir Soc Med Nat Iasi 2014; 118: 19-27.
89. El Eter E, Al Masri A, Habib S, Al Zamil H, Al Hersi A, Al Hussein F, Al Omran M. Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease. Cell Stress Chaperon 2014; 19: 173-81.
90. Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev 2015; 2015: 610813.
91. Ranford JC, Henderson B. Chaperonins in disease: mechanisms, models, and treatments. Mol Pathol 2002; 55: 209-13.
92. Bakthisaran R, Tangirala R, Rao CM. Small heat shock proteins: role in cellular functions and pathology. Biochim Biophys Acta 2015; 1854: 291-319.
93. Magrane J, Smith RC, Walsh K, Querfurth HW. Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed β-amyloid in neurons. J Neurosci 2004; 24: 1700-6.
94. Wu Y, Cao Z, Klein WL, Luo Y. Heat shock treatment reduces β amyloid toxicity in vivo by diminishing oligomers. Neurobiol Aging 2010; 31: 1055-8.
95. Cumming RC, Dargusch R, Fischer WH, Schubert D. Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid β-resistant nerve cells. J Biol Chem 2007; 282: 30523-34.
96. Cimini A, Gentile R, Angelucci F, Benedetti E, Pitari G, Giordano A, Ippoliti R. Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease model. J Cell Biochem 2013; 114: 708-15.
97. Davey GP, Bolanos JP. Peroxiredoxin 5 links mitochondrial redox signalling with calcium dynamics: impact on Parkinson's disease. J Neurochem 2013; 125: 332-3.
98. Krapfenbauer K, Yoo BC, Fountoulakis M, Mitrova E, Lubec G. Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jakob disease. Electropho-resis 2002; 23: 2541-7.
99. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 2004; 4: 3943-52.
100. Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol 2005; 110: 101-12.
101. Kim HT, Russell RL, Raina AK, Harris PL, Siedlak SL, Zhu X, Petersen RB, Shimohama S, Smith MA, Perry G. Protein disulfde isomerase in Alzheimer disease. Antioxid Redox Signal 2000; 2: 485-9.
102. Muchowski PJ. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 2002; 35: 9-12.
103. Tuite MF, Melki R. Protein misfolding and aggregation in ageing and disease: molecular processes and therapeutic perspectives. Prion 2007; 1: 116-20.
104. Honjo Y, Horibe T, Torisawa A, Ito H, Nakanishi A, Mori H, Komiya T, Takahashi R, Kawakami K. Protein disulfde isomer-ase P5-immunopositive inclusions in patients with Alzheimer's disease. J Alzheimers Dis 2014; 38: 601-9.
105. Jin J, Li GJ, Davis J, Zhu D, Wang Y, Pan C, Zhang J. Identifcation of novel proteins associated with both alpha-synuclein and DJ-1. Mol Cell Proteomics 2007; 6: 845-59.
106. Honjo Y, Kaneko S, Ito H, Horibe T, Nagashima M, Nakamura M, Fujita K, Takahashi R, Kusaka H, Kawakami K. Protein disulfde isomerase-immunopositive inclusions in patients with amyo-trophic lateral sclerosis. Amyotroph Lateral Scler 2011; 12: 444-50.
107. Honjo Y, Ito H, Horibe T, Shimada H, Nakanishi A, Mori H, Takahashi R, Kawakami K. Derlin-1-immunopositive inclusions in patients with Alzheimer's disease. Neuroreport 2012; 23: 611-5.
108. Farg MA, Soo KY, Walker AK, Pham H, Orian J, Horne MK, Warraich ST, Williams KL, Blair IP, Atkin JD. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfde-isomerase. Neurobiol Aging 2012; 33: 2855-68.
109. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA. S-nitrosylated protein-disulphide isomer-ase links protein misfolding to neurodegeneration. Nature 2006; 441: 513-7.
110. Uehara T. Accumulation of misfolded protein through nitrosa-tive stress linked to neurodegenerative disorders. Antioxid Redox Signal 2007; 9: 597-601.
111. Calabrese V, Sultana R, Scapagnini G, Guagliano E, Sapienza M, Bella R, Kanski J, Pennisi G, Mancuso C, Stella AM, Butterfeld DA. Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal 2006; 8: 1975-86.
112. Andreu CI, Woehlbier U, Torres M, Hetz C. Protein disulfde isomerases in neurodegeneration: from disease mechanisms to biomedical applications. FEBS Lett 2012; 586: 2826-34.
113. Hofstrom BG, Kaplan A, Letso R, Schmid RS, Turmel GJ, Lo DC, Stockwell BR. Inhibitors of protein disulfde isomerase suppress apoptosis induced by misfolded proteins. Nat Chem Biol 2010; 6: 900-6.
114. Atkin JD, Farg MA, Turner BJ, Tomas D, Lysaght JA, Nunan J, Rembach A, Nagley P, Beart PM, Cheema SS, Horne MK. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfde isomerase with superoxide dismutase 1. J Biol Chem 2006; 281: 30152-65.
115. Massignan T, Casoni F, Basso M, Stefanazzi P, Biasini E, Tortarolo M, Salmona M, Gianazza E, Bendotti C, Bonetto V. Proteomic analysis of spinal cord of presymptomatic amyo-trophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun 2007; 353: 719-25.
116. Nakamura T, Lipton SA. Cell death: protein misfolding and neurodegenerative diseases. Apoptosis 2009; 14: 455-68.
117. Xu B, Jin CH, Deng Y, Liu W, Yang T Y, Feng S, Xu ZF. Alpha-synuclein oligomerization in manganese-induced nerve cell injury in brain slices: a role of NO-mediated S-nitrosylation of protein disulfde isomerase. Mol Neurobiol 2014; 50: 1098-110.
118. Walker AK, Farg MA, Bye CR, Mclean CA, Horne MK, Atkin JD. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain 2010; 133: 105-16.
119. Jeon GS, Nakamura T, Lee JS, Choi WJ, Ahn SW, Lee KW, Sung JJ, Lipton SA. Potential efect of S-nitrosylated protein disulfde isomerase on mutant SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis. Mol Neurobiol 2014; 49: 796-807.
120. Hull J, Patel V, El Hindy M, Lee C, Odeleye E, Hezwani M, Love S, Kehoe P, Chalmers K, Conway M. Regional increase in the expression of the BCAT proteins in Alzheimer's disease brain: implications in glutamate toxicity. J Alzheimers Dis 2015; 45: 891-905.